Topic

Cardiology Group


Feature: CMS cuts could make hospitalists out of cardiologists

Top Stories | Thursday, November 05 2009
Written by Justine Cadet
Since the Centers for Medicare & Medicaid Services (CMS) issued its 2010 physician fee final rule last week with cuts to cardiology practices averaging 27 percent, the American College of Cardiology has expressed adamant opposition, and its CEO, Jack Lewin, MD, said that this will cause the shuttering of practices. However, former CMS Administrator Thomas A. Scully explained how the agency is limited by finite funding and growing pressures to fund other areas of healthcare.
 

Baltimore hospital settles with govt over dealings with cardiology group

Top Stories | Tuesday, July 28 2009
St. Joseph Medical Center in Towson, Md., near Baltimore, has reached an agreement with the federal government to settle claims that may arise during an investigation of a cardiology group with which the hospital has done business.


 


Web Exclusives

Commentary: Atrial fibrillation strikes an electrophysiologist

Middle age introduces itself in many ways; one is atrial fibrillation (AF). My onset of AF seems to have coincided with a mountain bike accident in the woods of North Carolina that resulted in some cracked ribs.

AHRQ: Health IT could be disruptive while reducing rehospitalization rates, costs

The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).

New patient monitoring model draws scrutiny

A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.

Commentary: Overcoming challenges with drug-eluting stents

There are cases presented to all physicians when we have to balance benefits of a particular treatment with concerns around safety for certain patients. In interventional cardiology, we see this dilemma with drug-eluting stents (DES). While this technology provides effective therapy for many patients with ischemia-inducing coronary lesions, there are certain patient groups that encounter problems for different reasons.